The addition of Australian trial sites is expected to facilitate a significantly greater proportion of the trial costs as being eligible for the R&D tax incentive cash rebate, which should have a material impact on reducing the cash requirements for the conduct of the study.
Very clever boxing
The addition of Australian trial sites is expected to facilitate...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $3.702K | 35.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 143769 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 225957 | 5 |
View Market Depth
| Last trade - 10.06am 27/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |